Neurofeedback Therapy is among the most exciting technological advances in medicine. Still in its infancy, studies are emerging that confirm what practitioners have been witnessing for years.
Research and clinical studies show many cognitive issues that are unresponsive to medication or psychotherapy, can be resolved within 20-40 Neurofeedback therapy sessions. Chronic, longstanding emotional and physical issues, including those complicated by substance abuse, can show marked improvement within 20 treatments.
(click above title to view the original study)
In 2009 one of the best clinical trials so far on the effectiveness of Neurofeedback on ADHD was published. In this trial, researchers studied 102 children with ADHD, age 8-12 years, for 36 sessions of Neurofeedback and compared it to 36 sessions of computerized attention skills training as a control. Researchers carefully rated progress using pre-training, intermediate and post-training assessments completed by parents and teachers. In their findings, researchers found that Neurofeedback was more effective than the control group doing only attention skills training and thus established clinical efficacy for Neurofeedback that was statistically significant.
In 2007 the Journal of Neurotherapy published a study demonstrating the effectiveness of Neurofeedback for Autism Spectrum Disorders. In this study, 37 patients were treated with 20 sessions of Neurofeedback Therapy. Compared with the control group, significant improvement was found in Autistics who received treatment. In fact, core ASD symptoms were reduced by 40%, with an 89% success rate!
“Research on autistic spectrum disorder (ASD) shows that neurofeedback (EEG biofeedback) can remediate anomalies in brain activation, leading to symptom reduction and functional improvement. This evidence raises the hopes for a behavioral, psychophysiological intervention moderating the severity of ASD.”
More Research on Neurofeedback
Many disorders have been shown to be successfully treated by Neurofeedback Therapy. For extensive discussions, case studies, clinical studies, and research information go to: